Age and comorbidities deeply impact on clinical outcome of patients with myelodysplastic syndromes. Issue 8 (August 2015)

• Record Type: Journal Article
• Authors: Balleari, E.; Salvetti, C.; Del Corso, L.; Filiberti, R.; Bacigalupo, A.; Bellodi, A.; Beltrami, G.; Bergamaschi, M.; Berisso, G.; Calzamiglia, T.; Carella, A.M.; Cavalleri, M.; Da Col, A.; Favorini, S.; Forni, G.L.; Goretti, R.; Miglino, M.; Mitscheuning, L.; Molinari, E.; Racchi, O.; Scudeletti, M.; Tassara, R.; Gobbi, M.; Lemoli, R.; Clavio, M.
• Is Part Of: Leukemia research. Volume 39:Issue 8(2015:Aug.)
• Page Start: 846
• Page End: 852
• Publication Date: 2015-08
• Subjects: Leukemia -- Periodicals; Leukemia -- Periodicals; Leucémie -- Périodiques; Leukemia; Periodicals; Electronic journals; Electronic journals; 616.9941905
• DOI: 10.1016/j.leukres.2015.05.007
• Languages: English
• ISSNs: 0145-2126

Abstract

<abstract abstract-type="author-highlights" id="abs0005"> <title id="sect0005">Highlights</title> <sec> <p id="spar0005"> <list id="lis0005"> <list-item id="lsti0005"> <label></label> <p id="par0005">We examine the effects of age and comorbidity in a real-life series of MDS patients.</p> </list-item> <list-item id="lsti0010"> <label></label> <p id="par0010">Both age and comorbidities exert a significant, independent impact on clinical outcome.</p> </list-item> <list-item id="lsti0015"> <label></label> <p id="par0015">The role of comorbidity in predicting outcome is best described by the MDS-CI score system.</p> </list-item> <list-item id="lsti0020"> <label></label> <p id="par0020">The impact of MDS-CI on outcome has particular relevance in lower-risk MDS patients.</p> </list-item> </list> </p> </sec> </abstract>